secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001493152-24-011787
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences posts corporate slide presentation dated March 27, 2024
--------------------------------------------------------------------------

- Presentation is posted on the company's investor relations website at www.evofem.com.
- Slide deck includes updates and summaries of Evofem's business, strategy, and pipeline.
- No specific financial results or material events were disclosed in the filing apart from the presentation.
- Company undertakes no obligation to update the materials attached as Exhibit 99.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224011787/0001493152-24-011787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224011787/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer